Work

EP08.02-020 Preclinical Activity of NVL-655 in a Patient-Derived NSCLC Model with Lorlatinib-Resistant ALK G1202R/T1151M Mutation

Year: 2022

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2022.07.702

Authors: H. Mizuta, L. Bigot, A. Tangpeerachaikul, H. Pelish, L. Friboulet

Institutions: Institut Gustave Roussy, Fondation Gustave Roussy, Nuvalent, Inc. (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4294942385

Cites:

Cited by: 2

Related to: 10